Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
---|
Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
---|
Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
---|
Capricor Therapeutics (NASDAQ:CAPR) reported its Q4 earnings results on Thursday, February 29, 2024 at 04:05 PM.
Here's what investors need to know about the announcement.
Capricor Therapeutics beat estimated earnings by 78.0%, reporting an EPS of $-0.02 versus an estimate of $-0.09.
Revenue was up $11.13 million from the same period last year.
Last quarter the company beat on EPS by $0.04 which was followed by a 7.000000000000001% increase in the share price the next day.
To track all earnings releases for Capricor Therapeutics visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Posted In: CAPR